• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: January 31-February 4, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

January 31-February 4, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs1/31/11New York, NYJohn Taylor, Mary Lou Valdez, Deborah Autor, Sharon Mayl, Richard Berman, Carolyn Becker, Ilisa Bernstein, Meghan Scott, Murray Lumpkin, Kanya Balakrishna N/ARemarks at the Council for Foreign Relations
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs1/31/11-2/4/11N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs1/31/11-2/4/11N/AN/AN/ANo Significant Meetings
Curtis L. Coy, Deputy Commissioner for Administration1/31/11-2/4/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products1/31/11-2/4/11 N/AN/AN/ANo Significant Meetings 
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget1/31/11-2/4/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine1/31/11-2/04/11N/AN/AN/ANo Significant Meetings 
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health1/31/11-2/4/11N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition1/31/11-2/4/11N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs1/31/11-2/4/11N/AN/AN/ANo Significant Meetings
Beth Martino, Associate Commissioner for External Affairs1/31/11-2/4/11N/AN/AN/ANo Significant  Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research1/31/11-2/4/11N/AN/AN/ANo Significant Meetings  
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health1/30/11-2/1/11London, United KingdomN/ASeveral representatives from HTAi Policy ForumMedical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/2/11Silver Spring, MDSeveral FDA officials and staff membersSeveral representatives from B&D Consulting Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/3/11Silver Spring, MDSeveral FDA officials and staff membersSeveral representatives from Austen Bioinnovation Institute Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/3/11Silver Spring, MDSeveral FDA officials and staff membersSeveral representatives from Cyberonics Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/4/11Silver Spring, MDSeveral FDA officials and staff membersSeveral representatives from Pricewaterhouse-Coopers Medical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research1/31/11-2/4/11N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods2/4/11TeleconferenceJeanne IrelandErik Olson, Caroline Brickey, Sandra Eskin (The Pew Charitable Trusts)Food Safety
Ralph Tyler, J.D., Chief Counsel2/2/11Washington, DCNathan BrownBIO's Biopharmaceutical Law CommitteeLegal issues relevant to BIO members
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs2/3/11Silver Spring, MDRosanne Hurwitz, Carla Cartwright, Laurie LenkelRonald Caiazza, Stephen Thong, Jeffrey Shapiro  (Church & Dwight)Arm & Hammer Enamel Care Brand Sensitive Toothpaste product classification appeal
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research1/31/11-2/4/11N/AN/AN/ANo Significant Meetings